bleedHD: a Tool for Assessment of Bleeding and Graftversus-Host Disease in Hemato-oncological Patients

被引：0
|
作者：
Egger, M. [1 ]
Halter, J. [2 ]
Infanti, L. [2 ,3 ]
Plattner, A. [4 ]
Schefer, S. [5 ]
Angerer, L. [5 ]
Kistler, J. [6 ]
Passweg, J. [2 ]
Buser, A. [1 ,2 ]
Holbro, A. [1 ,2 ]
机构：
[1] Swiss Red Cross, Blood Transfus Serv, Basel, Switzerland
[2] Univ Basel Hosp, Hematol, CH-4031 Basel, Switzerland
[3] Blood Transfus Ctr, Basel, Switzerland
[4] Swiss Red Cross, Basel, Switzerland
[5] Getunik AG, Zurich, Switzerland
[6] Kistler Web Act, Zurich, Switzerland
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB37
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [31] The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review
    M Franchini
    D Veneri
    G Lippi
    Bone Marrow Transplantation, 2007, 39 : 729 - 735
  • [32] Targeting Histone Deacetylases to Modulate GraftVersus-Host Disease and Graft-Versus-Leukemia
    Kim, Sena
    Santhanam, Srikanth
    Lim, Sora
    Choi, Jaebok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 20
  • [33] Akrokeratose Bazex bei hämatoonkologischer ErkrankungAcrokeratosis paraneoplastica in hemato-oncological disease
    Laura Engels
    Florian Kapp
    Thomas Ruzicka
    Tanja von Braunmühl
    Hans Wolff
    Der Hautarzt, 2018, 69 : 42 - 44
  • [34] Parenteral nutrition as a risk factor for port-infections in hemato-oncological patients
    Zink, M.
    Loeffler, C.
    Ulmer, M.
    Angermeier, S.
    Caca, K.
    Schwella, N.
    ONKOLOGIE, 2011, 34 : 258 - 258
  • [35] Hemato-oncological disorders in acquired immunodeficiency syndrome (AIDS) patients from Venezuela
    Soyano, N.
    Mueller, A.
    Monzon, A.
    Natale, A.
    Soyano, A. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 474 - 475
  • [36] Design and development of a multidimensional questionnaire to assess adaptation to illness in hemato-oncological patients
    Ulla, S
    Arranz, P
    Coca, C
    PSYCHOLOGY & HEALTH, 2005, 20 : 267 - 267
  • [37] Minimal residual disease post-bone marrow transplantation for hemato-oncological diseases
    Toren, A
    Rechavi, G
    Nagler, A
    STEM CELLS, 1996, 14 (03) : 300 - 311
  • [38] Allosteric Inhibition of MALT1 Is Efficacious in a Model of Chronic GraftVersus-Host Disease and Modulates Immunometabolic Activation
    Dispirito, Joanna R.
    Badur, Mehmet G.
    Biswas, Subhabrata
    Camacho, Diogo M.
    Chalishazar, Aditi
    De Christopher, Brian
    Sellers, Katie
    Steadman, Mya
    Soh, Keng
    Monroe, John
    Long, Andrew
    BLOOD, 2021, 138 : 3810 - +
  • [39] Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease
    Claas Baier
    Sibylle Haid
    Andreas Beilken
    Astrid Behnert
    Martin Wetzke
    Richard J. P. Brown
    Corinna Schmitt
    Ella Ebadi
    Gesine Hansen
    Thomas F. Schulz
    Thomas Pietschmann
    Franz-Christoph Bange
    Antimicrobial Resistance & Infection Control, 7
  • [40] Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease
    Baier, Claas
    Haid, Sibylle
    Beilken, Andreas
    Behnert, Astrid
    Wetzke, Martin
    Brown, Richard J. P.
    Schmitt, Corinna
    Ebadi, Ella
    Hansen, Gesine
    Schulz, Thomas F.
    Pietschmann, Thomas
    Bange, Franz-Christoph
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
12345